Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financi...(ED BY (USED IN) INVESTING ACTIVITIES...),Health

Date:4/22/2009

ED BY (USED IN) INVESTING ACTIVITIES (41,901,488) (381,772) CASH FLOWS FROM FINANCING ACTIVITIES: Net proceeds (payments) from convertible debt (2,520,000) 2,950,000 Proceeds from sale of convertible redeemable preferred stocks 5,000,000 -- Payment of debt issuance costs (468,568) (231,526) Proceeds from related party advances 965,986 1,061,009 Repayments of related party advances (1,996,481) (816,732) Repayments of notes payable - related parties -- 509,351 NET CASH PROVIDED BY FINANCING ACTIVITIES 980,937 3,472,102 EFFECT OF EXCHANGE RATE ON CASH 247,318 228,926 NET (DECREASE) INCREASE IN CASH (3,279,149) 2,468,801 CASH - beginning of year 4,557,957 2,089,156 CASH - end of year $1,278,808 $4,557,957 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for: Interest $103,250 $477,001 Income taxes $-- $-- Non-cash investing and financing activities: Warrants issued for prepaid financing costs $327,565 $-- Warrants issued for consulting $178,187 $-- Common stock issued for compensation $318,551 $-- Common stock issued for conversion of convertible debt $250,000 $230,000 Debt discount for grant of warrants and beneficial conversion feature $2,310,263 $1,616,839 Due from related p
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related medicine news :

1. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
2. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
3. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
4. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
5. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
6. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
9. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
10. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
11. Lotus Pharmaceuticals Raises $5 Million in Private Placement